Abiopharma

NeuroSense Granted U.S. Patent for Treatment of Alzheimers Disease

NeuroSense Granted U.S. Patent for Treatment of Alzheimers Disease

Hoth Therapeutics Notification (HOTH)

Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Healths Most Evidence-Based Platforms

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247

DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE

DuPont Schedules Fourth Quarter 2025 Earnings Conference Call

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

Ensysce Biosciences Expands Global Opioid Patent Portfolio